Skip to main content
SpringerLink
Log in

Ibandronate

A Viewpoint by Ingo J. Diel

  • Adis New Drug Profiles
  • Guest Commentary
  • Published:
Drugs Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Pecherstofer M, Ludwig H, Schlosser K, et al. Administration of the bisphosphonate ibandronate (BM 21.0955) by intravenous bolus injection. J Bone Miner Res 1996 May; 11(5): 587–93

    Article  Google Scholar 

  2. Thiébaud D, Burckhardt P, Kriegbaum H, et al. Three monthly intravenous injections of ibandronate in the treatment of postmenopausal osteoporosis. Am J Med 1997; 103: 298–307

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. University Hospital, Heidelberg, Germany

    Ingo J. Diel

Authors
  1. Ingo J. Diel
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Diel, I.J. Ibandronate. Drugs 57, 109 (1999). https://doi.org/10.2165/00003495-199957010-00013

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00003495-199957010-00013

Search

Navigation